National Kidney Foundation: Statement on Kidney Patient Prioritization for COVID-19 Vaccines and Therapeutics
December 18, 2020
December 18, 2020
NEW YORK, Dec. 18 (TNSRep) -- The National Kidney Foundation issued the following statement:
* * *
The National Kidney Foundation (NKF), representing the more than 37 million adults in the U.S. with kidney disease, their families, and the professionals who care for them, believes that a key principle of ethical vaccine allocation must be that the vaccine is made available to patients at the highest risk of severe outcomes from COVID-19 infection.
According . . .
* * *
The National Kidney Foundation (NKF), representing the more than 37 million adults in the U.S. with kidney disease, their families, and the professionals who care for them, believes that a key principle of ethical vaccine allocation must be that the vaccine is made available to patients at the highest risk of severe outcomes from COVID-19 infection.
According . . .